Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03258398
Title A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Effector Therapeutics
Indications

colorectal adenocarcinoma

Therapies

Avelumab + Tomivosertib

Tomivosertib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.